OPRL1 Antikörper (C-Term)

Produktnummer ABIN6258295

Produktdetails anti-OPRL1 Antikörper

Target: OPRL1 (Opiate Receptor-Like 1 (OPRL1))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser OPRL1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Spezifität: OPRL1 Antibody detects endogenous levels of total OPRL1.

Homologie: Pig,Horse,Sheep,Dog

Aufreinigung: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogen: A synthesized peptide derived from human OPRL1, corresponding to a region within C-terminal amino acids.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:500-1:2000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Haltbarkeit: 12 months

Details zu OPRL1

Target: OPRL1 (Opiate Receptor-Like 1 (OPRL1))

Andere Bezeichnung: OPRL1 (OPRL1 Produkte)

Synonyme: KOR-3 antikoerper, NOCIR antikoerper, OOR antikoerper, ORL1 antikoerper, KOR3 antikoerper, LC132 antikoerper, MOR-C antikoerper, OFQR antikoerper, Oprl antikoerper, XOR1 antikoerper, OPRL antikoerper, ORGC antikoerper, morc antikoerper, opioid related nociceptin receptor 1 antikoerper, opiate receptor-like 1 L homeolog antikoerper, opiate receptor-like 1 antikoerper, opioid receptor-like 1 antikoerper, OPRL1 antikoerper, oprl1.L antikoerper, LOC100335303 antikoerper, Oprl1 antikoerper

Hintergrund:

Description: G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.

Gene: OPRL1

Molekulargewicht: 41 kDa,

Gen-ID: 4987

UniProt: P41146